Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort von Vanni, I, Pastorino, L, Andreotti, V, Comandini, D, Fornarini, G, Grassi, M, Puccini, A, Tanda, E T, Pastorino, A, Martelli, V, Mastracci, L, Grillo, F, Cabiddu, F, Guadagno, A, Coco, S, Allavena, E, Barbero, F, Bruno, W, Dalmasso, B, Bellomo, S E, Marchiò, C, Spagnolo, F, Sciallero, S, Berrino, E, Ghiorzo, P

Volltext

Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis von Comandini, D, Grassi, M, Prelaj, A, Martelli, V, Damiani, A, Damiano, G, Rebuzzi, S Elena

Volltext

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer von Gandini, A., Martelli, V., Belgioia, L., Puglisi, S., Cremante, M., Murianni, V., Damassi, A., Pirrone, C., Catalano, F., Grassi, M., Trevisan, L., Vagge, S., Andretta, V., Mammoliti, S., Comandini, D., Fornarini, G., Pessino, A., Pastorino, A., Sciallero, S., Puccini, A., Sobrero, A.F.

Volltext

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab von Siena, S, Peeters, M, Van Cutsem, E, Humblet, Y, Conte, P, Bajetta, E, Comandini, D, Bodoky, G, Van Hazel, G, Salek, T, Wolf, M, Devercelli, G, Woolley, M, Amado, R G

Volltext

Molecular characterization of an Italian series of sporadic GISTs von Origone, P., Gargiulo, S., Mastracci, L., Ballestrero, A., Battistuzzi, L., Casella, C., Comandini, D., Cusano, R., Dei Tos, A. P., Fiocca, R., Garuti, A., Ghiorzo, P., Martinuzzi, C., Toffolatti, L., Bianchi Scarrà, G.

Volltext

First-line single-agent cetuximab in patients with advanced colorectal cancer von Pessino, A., Artale, S., Sciallero, S., Guglielmi, A., Fornarini, G., Andreotti, I.C., Mammoliti, S., Comandini, D., Caprioni, F., Bennicelli, E., Andretta, V., Siena, S., Sobrero, A.

Volltext

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies von Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A.F., Mazzola, G., Lambiase, A., Bordignon, C.

Volltext

Impact of a multidisciplinary team in the outcome of sarcoma patients von Mascherini, M., Fumagalli, G., Santoliquido, M., Di Domenico, S., Papadia, F., Comandini, D., De Cian, F.

Volltext

Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients von Repetto, L., Comandini, D., Mammoliti, S.

Volltext

445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state von Pastorino, A., Puccini, A., Martelli, V., Grassi, M., Cremante, M., Gandini, A., Puglisi, S., Catalano, F., Murianni, V., Pessino, A., Andretta, V., Mammoliti, S., Sciallero, M.S., Comandini, D., Fornarini, G., Caprioni, F., Bregni, G., Barni, S., Labianca, R., Sobrero, A.F.

Volltext

56P Pembrolizumab in advanced mesenchymal tumors: A prospective monocentric study von Cremante, M., Catalano, F., Comandini, D., Mascherini, M., Zaottini, F., Picasso, R., Spina, B., Guadagno, A., Grassi, M.

Volltext

6075 A triple combination of Imatinib, Bevacizumab and Cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer von Pessino, A, Andretta, V, Guglielmi, A, Mammoliti, S, Caprioni, F, Fornarini, G, Comandini, D, Sciallero, S, Ansaldi, F, Sobrero, A

Volltext

6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard... von Sobrero, A.F, Pessino, A, Andretta, V, Bennicelli, E, Fornarini, G, Caprioni, F, Comandini, D, Orsino, L, Lambiase, A, Bordignon, C

Volltext

Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability von VENTURINO, Antonella, COMANDINI, Danila, GRANETTO, Cristina, AUDISIO, Riccardo Alberto, CASTIGLIONE, Federico, ROSSO, Riccardo, REPETTO, Lazzaro

Volltext

Cancer in the elderly: assessing patients for fitness von Repetto, Lazzaro, Comandini, Danila

Volltext

Phase II trial of imatinib, bevacizumab and cetuximab plus modified FOLFOX-6 in advanced untreated colorectal cancer von Sobrero, A. F., Bennicelli, E., Pessino, A., Guglielmi, A., Mammoliti, S., Caprioni, F., Fornarini, G., Comandini, D., Sciallero, S., Ansaldi, F.

Volltext

Radiation‐associated angiosarcoma: Diagnostic and therapeutic implications—Two case reports and a review of the literature von Cafiero, Ferdinando, Gipponi, Marco, Peressini, Alberto, Queirolo, Paola, Bertoglio, Sergio, Comandini, Danila, Percivale, Pierluigi, Sertoli, Mario Roberto, Badellino, Fausto

Volltext

Cancer in the elderly: assessing patients for fitness: Special issue in honor of the First Meeting of the International Society of Geriatric Oncology (SIOG) von REPETTO, L, COMANDINI, D

Volltext

Combined craniofacial approach to facial tumours involving the anterior skull base von Margarino, G., Scala, M., Mereu, P, Comandini, D., Schenone, G., Galli, A., Francaviglia, N., Gipponi, M.

Volltext

Tumor response to imatinib mesylate in advanced GIST von Casali, P. G., Fumagalli, E., Messina, A., Spreafico, C., Comandini, D., Comandone, A., De Giorgi, U., Frustaci, S., Vinaccia, V., Marré Brunenghi, M. C.

Volltext